Rallybio Corp Share Price

NASDAQ: RLYB

Small Cap

$0.57

-0.03

(-4.85%)

as on September 18, 2025 at 1:29 am IST

$₹

Rallybio Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$0.57
Day's Price Range
$0.6
$0.57
5.26%
Upside
52 Week's Low
52 Week's High
$0.22
52-Week Price Range
$1.24
$0.57
61.39%
Downside
117.56%
Upside

Rallybio Corp share price movements today

Previous Close: $0.60
Open: $0.60
Volume: 579.0K
Day's Low - High: $0.57 - $0.6
52 Week Low - High: $0.22 - $1.24

Rallybio Corp Historical Returns

1 Month Return: -0.7 %
3 Month Return: + 77.46 %
1 Year Return: -45.47 %
3 Year Return: -95.68 %
5 Year Return: 0 %

Rallybio Corp Stock Fundamentals & Key Indicators

Check Rallybio Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$24.8M

EPS (TTM)

-0.825

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-41.6M

Revenue (TTM)

761.0K

Profit Margin

0.00%

Return On Equity TTM

72457100.00%

Rallybio Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rallybio Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rallybio Corp	BUY	$24.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Rallybio Corp Stock including INR - Dollar returns

The Rallybio Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rallybio Corp investment value today

Current value as on today

₹56,416

Returns

₹43,584

(-43.58%)

Returns from Rallybio Corp Stock

₹48,182 (-48.18%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Rallybio Corp Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Rallybio Corp. Average target price of $1

Rallybio Corp Share Price Target

Get share price movements and forecasts by analysts on Rallybio Corp.

What analysts predicted

43%UPSIDE

Target Price

Current Price

$0.57

Analyzed by

12 Analysts

Target

$1.00

Rallybio Corp target price $1, a slight upside of 43% compared to current price of $0.57. According to 12 analysts rating.

Rallybio Corp Stock's Interest Amongst Investors

Search interest for Rallybio Corp Stock has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-66% versus previous 30 day period

Rallybio Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-18	-20	-19	-21	-19	-17	-12	-11	-9	-10
EBITDA	-18	-20	-19	-21	-19	-17	-12	-11	-9	-10
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-18	-18	-20	-19	-16	-11	-11	-9	-9
Income Tax Expense	-1	0	0	0	0	0	-	0	-	0
Net Income	-15	-18	-18	-20	-19	-16	-11	-11	-9	-9
Net Profit Margin	0.00%	0.00%	0.00%	-8878.07%	0.00%	-5430.10%	-3834.78%	-29063.16%	-4452.36%	-4576.89%

Rallybio Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	0
Gross Profit	0	0	0	0	0	0
Operating Income	-17	-25	-45	-67	-78	-60
EBITDA	-17	-24	-45	-65	-72	-60
Interest Expense	0	0	0	2	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	-17	-24	-45	-65	-74	-57
Income Tax Expense	0	0	1	0	-2	-2
Net Income	-17	-26	-47	-66	-74	-57
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-9084.12%

Rallybio Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-18	-18	-20	-19	-16	-11	-11	-9	-9
Operating Cash Flow	-13	-16	-11	-15	-10	-13	-9	-10	-8
Investing Cash Flow	6	3	16	10	2	22	-1	11	3
Financing Cash Flow	0	-	0	-	5	0	0	-	0
Change in Cash	-6	-13	5	-5	-2	8	-11	0	-5

Rallybio Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-26	-47	-66	-74	-57
Operating Cash Flow	-22	-45	-57	-60	-49
Investing Cash Flow	-2	-2	-112	27	33
Financing Cash Flow	144	82	51	0	5
Change in Cash	120	35	-118	-32	-10

Global Institutional Holdings in Rallybio Corp

Funds	Holdings
Viking Global Investors LP	10.08%
Johnson & Johnson	8.74%
5AM Venture Management, LLC	8.72%
New Leaf Venture Partners, L.L.C.	7.93%
TPG GP A, LLC	7.28%

See all

Insights on Rallybio Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, RLYB stock has moved up by 77.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 113.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 212.2%

About Rallybio Corp

rallybio is a privately-held early-stage biotechnology company incorporated in january 2018. our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development. we will work on highly-promising drug candidates that have strong biological rationales and that can be addressed using the well-validated therapeutic modalities of small molecules, engineered proteins, and antibodies. rallybio’s founders are seasoned leaders from the biopharma industry with a wide breadth of research, development, and financial experience. the company is based in farmington, ct, at the university of connecticut’s technology incubation program. we are assembling a small team of people with an outstanding track record in pharmaceutical research and development to search for and evaluate assets using a series of robust clinical and commercial filters tha

Organisation	Rallybio Corp
Headquarters	234 Church Street, New Haven, CT, United States, 06510
CEO	Dr. Stephen Uden M.B, M.D.
E-voting on shares	Click here to vote

Key Management of Rallybio Corp

Name	Title
Dr. Martin W. MacKay Ph.D.	Co-Founder & Chairman
Dr. Stephen Uden M.B, M.D.	Co-Founder, President, CEO & Director
Mr. Jonathan I. Lieber M.B.A.	CFO & Treasurer
Dr. Steven W. Ryder F.A.C.P, M.D.	Chief Medical Officer

FAQs

What is Rallybio Corp share price today?

Rallybio Corp share price today is $0.57 as on September 18, 2025 at 1:29 am IST at the close of the market. Rallybio Corp share today touched a day high of $0.6 and a low of $0.57.

What is the 52 week high and 52 week low for Rallybio Corp share?

Rallybio Corp share touched a 52 week high of $1.24 on December 11, 2024 and a 52 week low of $0.22 on April 8, 2025. Rallybio Corp stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.57,which is 54.04% down from its 52 week high and 158.97% up from its 52 week low.

What is Rallybio Corp's market capitalisation today?

Rallybio Corp market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Rallybio Corp Stock (RLYB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rallybio Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rallybio Corp Shares that will get you 2.6316 shares as per Rallybio Corp share price of $0.57 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rallybio Corp Stock (RLYB) from India?

Indian investors can start investing in Rallybio Corp (RLYB) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Rallybio Corp stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:40 am IST). Based on Rallybio Corp share’s latest price of $0.57 as on September 18, 2025 at 1:29 am IST, you will get 17.5439 shares of Rallybio Corp. Learn more about fractional shares .